• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 7 of 7 Results
Document Number k972639
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Tina-quant Haptoglobin ver.2} 
CR260235 k972639 Haptoglobin General Chemistry MODERATE 05/06/2026
Roche Diagnostics, cobas c 303  {Tina-Quant Haptoglobin Ver.2} 
CR220436 K972639 Haptoglobin General Chemistry MODERATE 12/05/2022
Roche Diagnostics cobas c 503 analytical unit  {Tina-quant Haptoglobin Gen.2} 
CR200052 K972639 Haptoglobin General Chemistry MODERATE 02/19/2020
Roche Diagnostics cobas c 701 haptoglobin  
K972639 K972639 Haptoglobin General Chemistry MODERATE 09/14/2011
Roche Diagnostics cobas c 702 haptoglobin  
K972639 K972639 Haptoglobin General Chemistry MODERATE 09/14/2011
Roche Diagnostics cobas c 502 Analyzer  
K100853 K972639 Haptoglobin General Chemistry MODERATE 01/10/2011
Roche Diagnostics cobas c 311 Analyzer  {Tina-Quant Haptoglobin Ver.2} 
K972639 K972639 Haptoglobin General Chemistry MODERATE 02/19/2009

-
-